Celdara Medical, LLC announced today that it has appointed Jan van de Winkel, Ph.D. to its Board of Directors, and elected him as a Member of the Company.
“We are honored and excited that Jan is joining our Board,” said Jake Reder, Ph.D., cofounder and CEO of Celdara Medical. “His impressive leadership as CEO of Genmab in addition to his academic accomplishments as Professor at Utrecht University make him ideally suited to advance Celdara Medical’s model and support future growth. His unique industry and scientific expertise, sharp intellect, and boundless energy are already making an impact at Celdara Medical.”
“On behalf of the Board, we’re very happy to welcome Jan to Celdara Medical,” said Michael Fanger, Ph.D., cofounder, Chairman, and CSO. “Jan’s depth in both science and business are uncommon. His perspectives as both a leader in industry and in the academy are unique. Most important, his character and commitment to improving human health are beyond compare. We all look forward to working with him to meet this challenge at Celdara Medical.”
Dr. van de Winkel is a co-founder of Genmab, the author of over 300 scientific publications and has been responsible for over 40 patents and pending patent applications. Dr. van de Winkel holds a professorship in Immunology at Utrecht University. He is chairman of the board of directors of Regenesance and member of the board of directors of ISA Pharmaceuticals, the scientific advisory board of Thuja Capital Healthcare Fund and the advisory board of Capricorn Health-tech Fund. He holds M.S. and Ph.D. degrees from the University of Nijmegen.
About Celdara Medical, LLC
Celdara Medical was founded by Drs. Jake Reder and Michael Fanger in 2008, and is headquartered at the Dartmouth Regional Technology Center (DRTC) in Lebanon, NH. Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market. Celdara Medical partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery and profitability. With robust funding options, a diverse and high impact Programmatic pipeline, and partnerships with world-class academic institutions and industry leaders, Celdara Medical navigates all aspects of a complex industry, accelerating science to improve human health.